Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1FELODIPINE

02 1FLECTOR

03 1LEVETIRACETAM

04 2LIDOCAINE

05 1LIDODERM

06 1RIFATER

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

ISONIAZID; PYRAZINAMIDE; RIFAMPIN

Drug : RIFATER

Dosage Form : TABLET; ORAL

Application Number : 50705

Country : US

Patented : No

Sanofi Company Banner

02

2024 ACI Convention
Not Confirmed
arrow

03

2024 ACI Convention
Not Confirmed
arrow

04

2024 ACI Convention
Not Confirmed
arrow

05

2024 ACI Convention
Not Confirmed
arrow

06

2024 ACI Convention
Not Confirmed
arrow

07

ADAPTIS

Levetiracetam

2024 ACI Convention
Not Confirmed
arrow
ADAPTIS
arrow
2024 ACI Convention
Not Confirmed

LEVETIRACETAM

Drug : LEVETIRACETAM

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 202167

Country : US

Patented : No

blank